Shuang Qiao

Design, Synthesis, and Evaluation of VHL-Based EZH2 Degraders to Enhance Therapeutic Activity against Lymphoma.

Peng Huang, Zifeng Wang, S. Wen, 2021, Journal of medicinal chemistry.

Reductive TCA cycle catalyzed by wild-type IDH2 promotes acute myeloid leukemia and is a metabolic vulnerability for potential targeted therapy

Peng Huang, Hui Zhang, S. Wen, 2022, Journal of Hematology & Oncology.

Tumor-derived lactate inhibit the efficacy of lenvatinib through regulating PD-L1 expression on neutrophil in hepatocellular carcinoma

Zhenfeng Zhang, Xiong-ying Jiang, N. Lyu, 2021, Journal for ImmunoTherapy of Cancer.

Wild-type IDH2 protects nuclear DNA from oxidative damage and is a potential therapeutic target in colorectal cancer

C. Glorieux, Peng Huang, S. Wen, 2021, Oncogene.

Highly Reactive Cyclic Monoaryl Iodoniums Tuned as Carbene Generators Couple with Nucleophiles under Metal-Free Conditions

Wenbin Zeng, Hui Peng, Peng-mian Huang, 2020, iScience.

Design, synthesis and biological evaluation of N-arylsulfonyl carbazoles as novel anticancer agents

R. Pi, S. Wen, Yumin Hu, 2018, RSC advances.